ATE193560T1 - Analytisches und therapeutisches mittel - Google Patents

Analytisches und therapeutisches mittel

Info

Publication number: ATE193560T1
Authority: AT; Austria
Prior art keywords: analytical; therapeutic agent; agent; oxoquanine; oxodeoxyadenosine
Prior art date: 1995-05-31

Application number

AT96901878T

Other languages

English (en)

Inventor

Sian Myra Thomas

Original Assignee

Univ Leicester

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-05-31

Filing date

1996-02-05

Publication date

2000-06-15

1996-02-05 Application filed by Univ Leicester filed Critical Univ Leicester

2000-06-15 Application granted granted Critical

2000-06-15 Publication of ATE193560T1 publication Critical patent/ATE193560T1/de

Links

239000003814 drug Substances 0.000 title 1
229940124597 therapeutic agent Drugs 0.000 title 1
RGKBRPAAQSHTED-UHFFFAOYSA-N 8-oxoadenine Chemical compound NC1=NC=NC2=C1NC(=O)N2 RGKBRPAAQSHTED-UHFFFAOYSA-N 0.000 abstract 2
HCAJQHYUCKICQH-VPENINKCSA-N 8-Oxo-7,8-dihydro-2'-deoxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@H]1C[C@H](O)[C@@H](CO)O1 HCAJQHYUCKICQH-VPENINKCSA-N 0.000 abstract 1
MIWVMNJJKIWXAS-KVQBGUIXSA-N 9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-iminopurin-8-one Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(=N)C2=NC1=O MIWVMNJJKIWXAS-KVQBGUIXSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Analytical Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Pathology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

AT96901878T 1995-05-31 1996-02-05 Analytisches und therapeutisches mittel ATE193560T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9510954.2A GB9510954D0 (en)	1995-05-31	1995-05-31	Detection of DNA damage
PCT/GB1996/000220 WO1996038588A1 (en)	1995-05-31	1996-02-05	Analytical and therapeutic agents

Publications (1)

Publication Number	Publication Date
ATE193560T1 true ATE193560T1 (de)	2000-06-15

Family

ID=10775254

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96901878T ATE193560T1 (de)	1995-05-31	1996-02-05	Analytisches und therapeutisches mittel

Country Status (10)

Country	Link
US (1)	US6309825B1 (de)
EP (1)	EP0828854B1 (de)
JP (1)	JP3510267B2 (de)
AT (1)	ATE193560T1 (de)
AU (1)	AU704928B2 (de)
CA (1)	CA2222513C (de)
DE (1)	DE69608683T2 (de)
ES (1)	ES2149448T3 (de)
GB (1)	GB9510954D0 (de)
WO (1)	WO1996038588A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6187551B1 (en) *	1995-09-19	2001-02-13	Cytochem, Inc.	Detection and quantitation of 8-OH-Adenine using monoclonal antibodies
WO2002065889A1 (de) *	2001-02-21	2002-08-29	Rubikon Ag	Verfahren zur untersuchung von zell- und gewebeproben
US7482029B2 (en)	2005-04-01	2009-01-27	Bionovo, Inc.	Composition for treatment of menopause
US20090042818A1 (en) *	2007-06-22	2009-02-12	Bionovo, Inc.	Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
AU2008296072A1 (en)	2007-09-07	2009-03-12	Bionovo, Inc.	Estrogenic extracts of Astragalus membranaceus Fisch.Bge.Var.mongolicus Bge. of the Leguminosae Family and uses thereof
US8512961B2 (en)	2007-11-19	2013-08-20	Bionovo, Inc.	Methods of detecting and treatment of cancers using Scutellaria barbata extract
EP2222323A4 (de)	2007-11-19	2012-07-25	Bionovo Inc	Verfahren zur herstellung eines gereinigten extrakts von scutellaria barbata d. don
EP2334814A4 (de) *	2008-09-05	2012-04-25	Solulink Biosciences Inc	Verfahren und zusammensetzungen für den direkten nachweis von dna-schäden

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992015707A1 (en)	1991-02-27	1992-09-17	New York University	Immunoassay for antibodies to oxidized dna and uses thereof

1995
- 1995-05-31 GB GBGB9510954.2A patent/GB9510954D0/en active Pending
1996
- 1996-02-05 DE DE69608683T patent/DE69608683T2/de not_active Expired - Lifetime
- 1996-02-05 AT AT96901878T patent/ATE193560T1/de not_active IP Right Cessation
- 1996-02-05 AU AU46278/96A patent/AU704928B2/en not_active Ceased
- 1996-02-05 WO PCT/GB1996/000220 patent/WO1996038588A1/en not_active Ceased
- 1996-02-05 ES ES96901878T patent/ES2149448T3/es not_active Expired - Lifetime
- 1996-02-05 EP EP96901878A patent/EP0828854B1/de not_active Expired - Lifetime
- 1996-02-05 JP JP53627496A patent/JP3510267B2/ja not_active Expired - Fee Related
- 1996-02-05 US US08/973,318 patent/US6309825B1/en not_active Expired - Fee Related
- 1996-02-05 CA CA002222513A patent/CA2222513C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0828854A1 (de)	1998-03-18
ES2149448T3 (es)	2000-11-01
AU704928B2 (en)	1999-05-06
US6309825B1 (en)	2001-10-30
JPH11507435A (ja)	1999-06-29
DE69608683D1 (de)	2000-07-06
CA2222513C (en)	2009-10-13
DE69608683T2 (de)	2001-02-08
WO1996038588A1 (en)	1996-12-05
EP0828854B1 (de)	2000-05-31
CA2222513A1 (en)	1996-12-05
GB9510954D0 (en)	1995-07-26
AU4627896A (en)	1996-12-18
JP3510267B2 (ja)	2004-03-22

Legal Events

Date	Code	Title	Description
2000-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
FI964339L (fi)	1996-10-28	Glukaanien entsyymikäsittely
FI972922L (fi)	1997-07-09	Tarkkaamattomuuden ja yliaktiivisuuden hoito
TR199901174T2 (xx)	1999-08-23	Yeni heterosiklilmetil-ikameli pirazol t�revleri.
ATE234092T1 (de)	2003-03-15	2-alkylpyrrolidine
ES2178093T3 (es)	2002-12-16	Derivados de epotilon y su preparacion.
DE69409360D1 (de)	1998-05-07	Neue antiparasitische mittel, derivate von milbemycin und avermectin
TR199600516A2 (tr)	1996-08-21	Kakaonun enzimatik muamelesi.
HN1996000017A (es)	2000-03-24	Isotiazolonas
ATE214924T1 (de)	2002-04-15	Verwendung von nebivolol als anti-atherogenisches mittel
NO996082L (no)	2000-02-08	Kontroll- og overvåkingssystem for kjemisk behandling av en oljebroenn
EP0883809A4 (de)	2001-05-16	Verfahren zur diagnostik von prostata-adenokarzinome
FI971802L (fi)	1997-04-28	Mycobacterium avium-kompleksilajien monistus ja ilmaisu
EP1015038A4 (de)	2004-04-07	Verfahren zur entdeckund, behandlung und vorbeugung von neurodegeneration
ATE248184T1 (de)	2003-09-15	Dns-sequenzen des humanen cytomegaloviruses
EP1011718A4 (de)	2003-01-08	Anti-virale behandlung mit pertussis toxin b oligomer
DE69608683D1 (de)	2000-07-06	Analytisches und therapeutisches mittel
DE59607236D1 (de)	2001-08-09	Bremskraftverstärker und montageverfahren hierfür
BG102064A (en)	1998-07-31	Method for increasing the retinal blood circulation
NO980251D0 (no)	1998-01-20	Behandling av konsentrasjonssvikt/hyperaktivitetsforstyrrelse
DE69611783D1 (de)	2001-03-22	Benzisoxazol- und indazol- derivate als antipsychotika
FR2786100B1 (fr)	2002-03-01	Nouvelle application therapeutique de la nicergoline
DE69717846D1 (de)	2003-01-23	Behandlungsverfahren von laktamen
HUP9802038A2 (hu)	1998-12-28	Eljárás eritropoietin-szerű glikoproteinek tisztítására
ES2173180T3 (es)	2002-10-16	Derivados del mercaptoacetilamida hipocolesterolemicos, antiateroescleroticos e hipotrigliceridemicos.
ID28174A (id)	2001-05-10	Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya